Literature DB >> 6778795

A double blind study of colchicine in Behçet's disease.

E Aktulga, M Altaç, A Müftüoglu, Y Ozyazgan, H Pazarli, Y Tüzün, B Yalçin, H Yazici, S Yurdakul.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6778795

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  37 in total

Review 1.  Behçet's disease: immunopathologic and therapeutic aspects.

Authors:  Robert Meador; George Ehrlich; Joan M Von Feldt
Journal:  Curr Rheumatol Rep       Date:  2002-02       Impact factor: 4.592

Review 2.  Behçet's disease.

Authors:  V Kontogiannis; R J Powell
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

3.  Behçet's Disease.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-09       Impact factor: 3.598

Review 4.  Behçet's syndrome: an update.

Authors:  Hasan Yazici
Journal:  Curr Rheumatol Rep       Date:  2003-06       Impact factor: 4.592

Review 5.  Behçet's syndrome.

Authors:  Yusuf Yazici; Sebahattin Yurdakul; Hasan Yazici
Journal:  Curr Rheumatol Rep       Date:  2010-12       Impact factor: 4.592

Review 6.  Practical treatment recommendations for pharmacotherapy of Behçet's syndrome.

Authors:  H Yazici; C G Barnes
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

Review 7.  Standard and novel therapeutic approaches to Behçet's disease.

Authors:  Ahmet Gul
Journal:  Drugs       Date:  2007       Impact factor: 9.546

8.  The anti-Helicobacter pylori antibiotherapy for the treatment of recurrent oral aphthous ulcers in a patient with Behcet's syndrome.

Authors:  Beytullah Yildirim; Mehmet Akif Oztürk; Selahattin Unal
Journal:  Rheumatol Int       Date:  2008-09-20       Impact factor: 2.631

9.  Behçet's Disease.

Authors:  Gulsen Akman-Demir; Sabahattin Saip; Aksel Siva
Journal:  Curr Treat Options Neurol       Date:  2011-06       Impact factor: 3.598

Review 10.  Pentoxifylline for the treatment of anterior uveitis in Behcet's disease: possible alternative for TNF blockers.

Authors:  Simone Appenzeller; Elizabeth Hazel
Journal:  Rheumatol Int       Date:  2009-12-16       Impact factor: 2.631
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.